119 related articles for article (PubMed ID: 37097692)
1. The Novel Use of IL-28 as an Effective Radiosensitizer in Pancreatic Cancer.
Chen X; Lee HY; Tang TT; Qin C; Prissel SA; Nelson CJ; Smith LA; Xiao H; Bai Q; Nicholl MB; Wakefield MR; Fang Y
Anticancer Res; 2023 May; 43(5):1885-1890. PubMed ID: 37097692
[TBL] [Abstract][Full Text] [Related]
2. IL-39 acts as a friend to pancreatic cancer.
Manning AA; Zhao L; Zhu Z; Xiao H; Redington CG; Ding VA; Stewart-Hester T; Bai Q; Dunlap J; Wakefield MR; Fang Y
Med Oncol; 2018 Dec; 36(1):12. PubMed ID: 30506430
[TBL] [Abstract][Full Text] [Related]
3. The novel role of IL-37 in prostate cancer: evidence as a promising radiosensitizer.
Ding VA; Zhu Z; Steele TA; Wakefield MR; Xiao H; Balabanov D; Fang Y
Med Oncol; 2017 Dec; 35(1):6. PubMed ID: 29210005
[TBL] [Abstract][Full Text] [Related]
4. Comparison of Radiosensitization by HDAC Inhibitors CUDC-101 and SAHA in Pancreatic Cancer Cells.
Moertl S; Payer S; Kell R; Winkler K; Anastasov N; Atkinson MJ
Int J Mol Sci; 2019 Jul; 20(13):. PubMed ID: 31269745
[TBL] [Abstract][Full Text] [Related]
5. IL-29 Exhibits Anti-Tumor Effect on Pan-48 Pancreatic Cancer Cells by Up-regulation of P21 and Bax.
Balabanov D; Zhao L; Zhu Z; Hunzeker ZE; Tonner HM; Ding VA; Wakefield MR; Bai Q; Fang Y
Anticancer Res; 2019 Jul; 39(7):3493-3498. PubMed ID: 31262873
[TBL] [Abstract][Full Text] [Related]
6. MGDG extracted from spinach enhances the cytotoxicity of radiation in pancreatic cancer cells.
Akasaka H; Mizushina Y; Yoshida K; Ejima Y; Mukumoto N; Wang T; Inubushi S; Nakayama M; Wakahara Y; Sasaki R
Radiat Oncol; 2016 Nov; 11(1):153. PubMed ID: 27876069
[TBL] [Abstract][Full Text] [Related]
7. Benzyl isothiocyanate sensitizes human pancreatic cancer cells to radiation by inducing apoptosis.
Ohara M; Kimura S; Tanaka A; Ohnishi K; Okayasu R; Kubota N
Int J Mol Med; 2011 Dec; 28(6):1043-7. PubMed ID: 21833466
[TBL] [Abstract][Full Text] [Related]
8. Influence of p53 status on radiation and 5-flourouracil synergy in pancreatic cancer cells.
Mohiuddin M; Chendil D; Dey S; Alcock RA; Regine W; Mohiuddin M; Ahmed MM
Anticancer Res; 2002; 22(2A):825-30. PubMed ID: 12014658
[TBL] [Abstract][Full Text] [Related]
9. Repositioning disulfiram as a radiosensitizer against atypical teratoid/rhabdoid tumor.
Lee YE; Choi SA; Kwack PA; Kim HJ; Kim IH; Wang KC; Phi JH; Lee JY; Chong S; Park SH; Park KD; Hwang DW; Joo KM; Kim SK
Neuro Oncol; 2017 Aug; 19(8):1079-1087. PubMed ID: 28340172
[TBL] [Abstract][Full Text] [Related]
10. Peptide tyrosine-tyrosine combined with its receptors exhibits an anti-cancer potential in pancreatic cancer MiaPaCa-2 cell.
Li H; Wang Z; Dong L; Jiang J; Xu X; Zhou L; Wan Y
Chin Med J (Engl); 2014; 127(24):4235-42. PubMed ID: 25533827
[TBL] [Abstract][Full Text] [Related]
11. Formulation Comprising Arsenic Trioxide and Dimercaprol Enhances Radiosensitivity of Pancreatic Cancer Xenografts.
Tang R; Zhu J; Liu Y; Wu N; Han J
Technol Cancer Res Treat; 2021; 20():15330338211036324. PubMed ID: 34433326
[TBL] [Abstract][Full Text] [Related]
12. Up and away with cervical cancer: IL-29 is a promising cytokine for immunotherapy of cervical cancer due to its powerful upregulation of p18, p27, and TRAILR1.
Ha JL; Kaser E; Guan T; Mayberry TG; Smith LA; D'mello K; Bai Q; Wakefield MR; Dong L; Fang Y
Med Oncol; 2024 Jan; 41(3):65. PubMed ID: 38281234
[TBL] [Abstract][Full Text] [Related]
13. Cranberry Extract Is a Potent Radiosensitizer for Glioblastoma.
Bai Q; Hunzeker ZE; Zhu Z; Lequio M; Willson CM; Xiao H; Wakefield MR; Fang Y
Anticancer Res; 2021 Jul; 41(7):3337-3341. PubMed ID: 34230129
[TBL] [Abstract][Full Text] [Related]
14. Harnessing the Power of Kiwifruit for Radiosensitization of Melanoma.
Kou L; Zhu Z; Fajardo E; Bai Q; Redington C; Xiao H; Lequio M; Sham N; Wakefield MR; Fang Y
Anticancer Res; 2021 Dec; 41(12):5945-5951. PubMed ID: 34848448
[TBL] [Abstract][Full Text] [Related]
15. Tolfenamic acid enhances pancreatic cancer cell and tumor response to radiation therapy by inhibiting survivin protein expression.
Konduri S; Colon J; Baker CH; Safe S; Abbruzzese JL; Abudayyeh A; Basha MR; Abdelrahim M
Mol Cancer Ther; 2009 Mar; 8(3):533-42. PubMed ID: 19258429
[TBL] [Abstract][Full Text] [Related]
16. Luminescent ruthenium(II) polypyridyl complexes acted as radiosensitizer for pancreatic cancer by enhancing radiation-induced DNA damage.
Zhou Y; Xu Y; Lu L; Ni J; Nie J; Cao J; Jiao Y; Zhang Q
Theranostics; 2019; 9(22):6665-6675. PubMed ID: 31588242
[No Abstract] [Full Text] [Related]
17. Radiosensitization effect of STI-571 on pancreatic cancer cells in vitro.
Chung HW; Wen J; Lim JB; Bang S; Park SW; Song SY
Int J Radiat Oncol Biol Phys; 2009 Nov; 75(3):862-9. PubMed ID: 19801102
[TBL] [Abstract][Full Text] [Related]
18. Identification of FES as a Novel Radiosensitizing Target in Human Cancers.
Kim BH; Kim YJ; Kim MH; Na YR; Jung D; Seok SH; Kim J; Kim HJ
Clin Cancer Res; 2020 Jan; 26(1):265-273. PubMed ID: 31573955
[TBL] [Abstract][Full Text] [Related]
19. Type I interferons as radiosensitisers for pancreatic cancer.
Morak MJ; van Koetsveld PM; Kanaar R; Hofland LJ; van Eijck CH
Eur J Cancer; 2011 Sep; 47(13):1938-45. PubMed ID: 21478011
[TBL] [Abstract][Full Text] [Related]
20. Torc1/Torc2 inhibitor, Palomid 529, enhances radiation response modulating CRM1-mediated survivin function and delaying DNA repair in prostate cancer models.
Gravina GL; Marampon F; Sherris D; Vittorini F; Di Cesare E; Tombolini V; Lenzi A; Jannini EA; Festuccia C
Prostate; 2014 Jun; 74(8):852-68. PubMed ID: 24715588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
